Clinical Trial Update: TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) [Phase 1, Phase 2]

View source ↗

Summary

Pfizer's TACTIVE-U study is evaluating Vepdegestrant in combination with other medicines for advanced or metastatic breast cancer (Sub-Study B). The Phase 1/2 t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Vepdegestrant (ARV-471)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING